COVID-19: a patient with cardiovascular disease at high risk
The COVID-19 pandemic that has swept the planet has posed many questions for doctors around the world, including the tactics of managing patients with cardiovascular disease, both infected and self-isolated. A symposium held with the support of the Merck company was devoted to this problem: "CO...
Guardado en:
Autores principales: | Irina E. Chazova, Y V Zhernakova, Olga D. Ostroumova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Morozov P.V.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b61330ead8d495d8c880a3caf622542 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020) -
COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020) -
Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021) -
Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
por: Marina Cecelja, et al.
Publicado: (2021) -
Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
por: Demosthenes Panagiotakos, et al.
Publicado: (2021)